Publication | Open Access
Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.
1.1K
Citations
39
References
1991
Year
AsthmaAcute Lung InjuryLung InflammationNitric OxideHypoxic Pulmonary VasoconstrictionPulmonary HypertensionSelective Pulmonary VasodilatorOxidative StressPulmonary PharmacologyPublic HealthPulmonary CirculationControl LambsPulmonary MedicineRespiration (Physiology)Pulmonary Vascular DiseasePulmonary Arterial HypertensionPhysiologyPulmonary PhysiologyLung MechanicsTissue OxygenationGas Nitric OxideMedicine
Background. The gas nitric oxide (NO) is an important endothelium-derived relaxing factor, inactivated by rapid combination with heme in hemoglobin. Methods and Results. Awake spontaneously breathing lambs inhaled 5-80 ppm NO with an acutely constricted pulmonary circulation due to either infusion of the stable thromboxane endoperoxide analogue U46619 or breathing a hypoxic gas mixture. Within 3 minutes after adding 40 ppm NO or more to inspired gas, pulmonary hypertension was reversed. Systemic vasodilation did not occur. Pulmonary hypertension resumed within 3-6 minutes of ceasing NO inhalation. During U46619 infusion pulmonary vasodilation was maintained up to 1 hour without tolerance. In the normal lamb, NO inhalation produced no hemodynamic changes. Breathing 80 ppm NO for 3 hours did not increase either methemoglobin or extravascular lung water levels nor modify lung histology compared with control lambs. Conclusions. Low dose inhaled NO (5-80 ppm) is a selective pulmonary vasodilator reversing both hypoxia- and thromboxane-induced pulmonary hypertension in the awake lamb [corrected].
| Year | Citations | |
|---|---|---|
Page 1
Page 1